COVID-19 Update for the Marfan, Loeys-Dietz, and VEDS Community
54:30-55:31
Q:
He has a question about being on warfarin therapy for about 40 years. Should he be concerned about potential clotting or related events upon vaccination?
40年間ワーファリンによる治療を受けておられる方からの質問です。ワクチン接種により血栓の問題などが生じることがあるかということです。
A:
I guess I'll take that one first. As, as Enid pointed out the, the frequency of the clotting disorder that was described with the J & J is incredibly rare. It's an immune response where one of the platelet factors is targeted with the response.
私から回答します。Enid先生からもありましたが、J&Jワクチンの接種による血栓症は非常に稀で、免疫反応により血小板因子の一つが標的となることが原因で生じます。
And, and so I, I would say that's exceedingly rare and our patients should continue to stay on the anticoagulant therapies that they were prescribed for a good reason and I would see no reason for them to adjust that strategy at the moment.
極めて稀な事象と言えますので、正当な理由があって抗凝固療法を受けておられる患者の皆さんは、引き続き継続してください。今のところ、治療方針を変える理由は見当たりません。
The Marfan Foundation did not participate in the translation of these materials and does not in any way endorse them. If you are interested in this topic, please refer to our website, Marfan.org, for materials approved by our Professional Advisory Board.
The Marfan Foundation は、当翻訳には関与しておらず、翻訳内容に関してはいかなる承認も行っておりません。このトピックに興味をお持ちの方は、Marfan.org にアクセスし、当協会の専門家から成る諮問委員会が承認した内容をご参照ください。
